We found that JSH-23 improved contractile dysfunction of DSPtv patient-derived EHTs, but we did not see this same effect with oridonin, suggesting the NF-κB inhibition is important for both contractile dysfunction and arrhythmia propensity (Supplemental Figure 8C). The gene discussed is NFKB1; the disease is Arrhythmia.